Gomes Brendo Araujo, Fernandes Diégina Araújo, Mendonça Simony Carvalho, Campos Mariana Freire, da Fonseca Thamirys Silva, Constant Larissa Esteves Carvalho, de Sousa Natalia Ferreira, Priscila Barros de Menezes Renata, de Oliveira Beatriz Albuquerque Custódio, da Silva Costa Stephany, Frensel Giovanna Barbosa, Rosa Alice Santos, Oliveira Thamara Kelcya Fonseca, Tucci Amanda Resende, Lima Júlia Nilo Henrique, Ferreira Vivian Neuza Santos, Miranda Milene Dias, Allonso Diego, Scotti Marcus Tullius, Leitão Suzana Guimarães, Leitão Gilda Guimarães
Programa de Pós-Graduação em Biotecnologia Vegetal e Bioprocessos, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil.
Departamento de Produtos Naturais e Alimentos, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil.
Int J Mol Sci. 2025 Jan 13;26(2):633. doi: 10.3390/ijms26020633.
The COVID-19 pandemic has caused over 7 million deaths globally in the past four years. spp. (Siparunaceae), which is used in Brazilian folk medicine, is considered a genus with potential antiviral alternatives. This study explored the correlation between phytochemicals in leaf extracts (, , , , and ) and their potential against various SARS-CoV-2 targets. In vitro assays examined interactions between the spike protein and the ACE2 receptor, protease activity, and viral replication inhibition in Calu-3 cell models. UHPLC-MS/MS analysis, processed with MZmine and evaluated chemometrically, revealed isoquinoline alkaloids with bulbocapnine, showing promising therapeutic potential. Predictions regarding absorption, distribution, metabolism, excretion, and toxicity were conducted, along with molecular docking and dynamics simulations, to evaluate protein-ligand interaction stability. The results confirmed the antiviral activity of the genus against SARS-CoV-2 targets, with 92% of the extracts maintaining over 70% cellular viability at 200 μg·mL and 80% achieving more than 50% viral activity suppression at 50 μg·mL. These findings highlight the potential of isoquinoline alkaloids as novel anti-coronavirus agents and support the need for further exploration, isolation, and testing of compounds in the fight against COVID-19.
在过去四年中,新冠疫情已在全球造成超过700万人死亡。巴西民间医学中使用的西帕鲁纳属(Siparunaceae)植物被认为是具有潜在抗病毒替代物的一个属。本研究探讨了 叶提取物( 、 、 、 和 )中的植物化学成分与其对各种新冠病毒靶点的潜在作用之间的相关性。体外试验检测了刺突蛋白与血管紧张素转换酶2(ACE2)受体之间的相互作用、蛋白酶活性以及在Calu-3细胞模型中的病毒复制抑制情况。采用MZmine进行处理并经化学计量学评估的超高效液相色谱-串联质谱(UHPLC-MS/MS)分析揭示了含有紫堇灵的异喹啉生物碱,显示出有前景的治疗潜力。进行了关于吸收、分布、代谢、排泄和毒性的预测,以及分子对接和动力学模拟,以评估蛋白质-配体相互作用的稳定性。结果证实了西帕鲁纳属植物对新冠病毒靶点的抗病毒活性,92%的提取物在200 μg·mL时保持超过70%的细胞活力,80%的提取物在50 μg·mL时实现超过50%的病毒活性抑制。这些发现突出了异喹啉生物碱作为新型抗冠状病毒药物的潜力,并支持在抗击新冠疫情中对 属化合物进行进一步探索、分离和测试的必要性。